Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.39%) to 8850.63, DAX (1.07%) to 23516.23, CAC40 (1.04%) to 7684.68, STOXX 600 (0.89%) to 544.94

Jun 13 ,2025

  • Synopsis:

    • European indices ended lower on back of big ramp in Middle East tensions as Israel conducted air strikes against Iran's nuclear and military facilities and killed senior military officials and nuclear scientists. Oil spike the big area of concern with WTI crude up 7%. While no mention of Israel targeting Iranian crude facilities, strikes have revived concerns about potential for Iran to retaliate by disrupting shipments through Strait of Hormuz. Travel/Leisure and Auto/Parts the worst performers, while Oil/Gas the only sector in positive territory.

    • In macro-news, significant drop in Eurozone Industrial Production in April (2.4%) m/m vs cons (1.6%) and prior revised +2.4% from +2.6%, while Trade Balance surplus narrowed sharply to €9.9B vs consensus €18.2B and prior €36.8B. Also, focus on final in-line CPI readings from Germany, France and Spain. Elsewhere, update from UK's REC/KPMG showed firms scaled back hiring further in May. BRC footfall data showed activity weakened in May despite good weather; total UK footfall decreased by 1.7% y/y vs 7.2% increase in April. Meanwhile, Spanish PM Sanchez under pressure after a top aide quit over graft allegations.

    • In M&A news, Novo Banco's majority shareholder - Lone Star- signed a MoU for the sale of Novo Banco to BPCE. Credit Agricole (ACA.FP) bought a majority stake in COMWATT, Shell Plc (SHEL.LN) will sell its 49% stake in Australian onshore wind farm developer WestWind, Norconsult (NORCO.NO) acquired the Aas-Jakobsen Group based on EV of NOK1.43B, Sandberg Development AB sold ~ SEK 1.3B worth of shares in Camurus (CAMX.SS). Proximus (PROX.BB) sold its majority stake in Be-Mobile to Arrive based on an EV of €170M and local Italian press reported that Antin and CVC funds are in the running to acquire Exor (EXO.NA) Lifenet Healthcare. Elsewhere, Fraport (FRA.GR) and Flughafen Zuerich (FHZN.SW) posted traffic numbers, whilst Fiskars (FSKRS.FH) lowered its FY guidance.

    • Looking ahead to next week EU econ-calendar, notable releases on Monday will include, amongst others, Italy May final CPI and Switzerland May PPI.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Oil & Gas +0.62%, Utilities (0.04%), Insurance (0.56%), Ind Goods & Svcs (0.57%), Basic Resources (0.57%), Food & Beverage (0.67%), Retail (0.70%), Telecom (0.82%), Health Care (0.88%)

      • Underperformers:

        • Autos & Parts (2.19%), Travel & Leisure (1.96%), Construct & Mtls (1.66%), Media (1.57%), Technology (1.52%), Financial Svcs (1.40%), Banks (1.24%), Persnl & HHold Goods (1.10%), Chemicals (1.07%), Real Estate (1.06%)

    • Macro:

      • Middle East tensions:

        • Why oil traders are watching the Strait of Hormuz -- FT

        • 'Deeply alarming': World leaders urge restraint as Israel pummels Iran -- Politico

      • G-7 Summit:

        • Everyone Is Watching Donald Trump:G-7 Leaders Guide -- Bloomberg

      • EU:

        • Germany wants next EU budget to focus on defence -- FT

        • EU trade surplus with US grows in April despite tariffs -- Reuters

        • France blocking Britain from EU's massive defence fund

      • UK:

        • UK Household Inflation Expectations Fell Before April CPI Spike -- Bloomberg

      • France:

        • France votes to abolish its low emission zones -- Route One

      • Spain:

        • Sánchez corruption scandals are a godsend for Spanish far right -- Politico

    • Company news:

      • Notable Gainers

        • +11.3% RNO.LN (Renold £0.84, +0.09) -- agrees on terms of a recommended cash acquisition by MPE Mgt at 82p/share

        • +7.2% SIGHT.FP (GenSight Biologics €0.22, +0.01) -- reaches an agreement with the ANSM for the opening of LUMEVOQ's Compassionate Access Program in France

        • +6.1% AGY.LN (Allergy Therapeutics £0.07, -0.00) -- study results

        • +4.7% EQNR.NO (Equinor NOK272.30, +12.20) -- granted drilling permit for wellbore 7117/4-1 in PL 1238

        • +4.1% MAERSK.B.DC (Maersk DKK12,650.00, +500.00) -- Israel launches airstrikes against Iran

        • +3.1% ODF.NO (Odfjell NOK115.80, +3.40) -- Israel launches airstrikes against Iran

        • +2.8% BA.LN (BAE Systems £19.45, +0.52) -- contract

        • +2.7% OKEA.NO (Okea NOK18.70, +0.48) -- Israel launches airstrikes against Iran

        • +2.6% DNORD.DC (D/S Norden DKK225.40, +5.60) -- Israel launches airstrikes against Iran

        • +1.9% PROX.BB (Proximus €7.93, +0.15) -- announces sale of its majority stake in Be-Mobile to Arrive based on an enterprise value of €170M

        • +1.6% BP.LN (BP £3.92, +0.06) -- Israel launches airstrikes against Iran

      • Notable Decliners

        • -6.5% SOI.FP (SOITEC €46.06, -3.16) -- Jefferies downgrade

        • -5.7% WIZZ.LN (Wizz Air Holdings £11.22, -0.68) -- Israel launches airstrikes against Iran

        • -4.8% FIA1S.FH (Finnair €2.74, -0.14) -- Israel launches airstrikes against Iran

        • -4.7% AF.FP (Air France-KLM €8.18, -0.41) -- Israel launches airstrikes against Iran

        • -4.2% JET2.LN (Jet2 £17.89, -0.78) -- Israel launches airstrikes against Iran

        • -3.9% FRA.GR (Fraport €60.50, -2.45) -- traffic numbers

        • -3.8% IAG.LN (International Consolidated Airlines Group £3.13, -0.12) -- Israel launches airstrikes against Iran

        • -3.7% NAS.NO (Norwegian Air Shuttle NOK12.87, -0.49) -- Israel launches airstrikes against Iran

        • -3.5% AC.FP (Accor €43.16, -1.55) -- Israel launches airstrikes against Iran

        • -3.4% TUI1.GR (TUI Group €6.40, -0.22) -- Israel launches airstrikes against Iran

        • -3.4% FHZN.SW (Flughafen Zuerich CHF225.00, -8.00) -- traffic numbers

        • -3.0% OXIG.LN (Oxford Instruments £17.92, -0.56) -- FY earnings

        • -3.0% ENW.LN (Enwell Energy £0.16, -0.01) -- FY earnings

        • -2.9% RYA.ID (Ryanair Holdings €23.06, -0.70) -- Israel launches airstrikes against Iran

        • -2.8% ALPHA.GA (Alpha Services & Holdings €2.70, -0.08) -- Wood & Company downgrade

        • -2.7% LHA.GR (Deutsche Lufthansa €6.82, -0.19) -- Israel launches airstrikes against Iran

        • -2.6% CLAS.B.SS (Clas Ohlson SEK327.20, -8.80) -- Kepler Cheuvreux and Pareto downgrades

        • -2.6% EZJ.LN (EasyJet £5.38, -0.15) -- Israel launches airstrikes against Iran

        • -2.4% CAMX.SS (Camurus SEK603.50, -15.00) -- Sandberg Development AB initiates accelerated bookbuilding process for sale of shares in company, worth ~ SEK 1.3B

        • -2.3% SHLF.NO (Shelf Drilling NOK8.17, -0.19) -- initiated hold at Pareto

        • -2.2% ANA.SM (Acciona €145.60, -3.30) -- surprised by reports of certain irregularities in public procurement at its Acciona construcción subsidiary

        • -2.0% BPSO.IM (Banca Popolare di Sondrio €11.56, -0.24) -- says BPER Banca's valuation of BPSO fails to fully recognise the real value of the bank

        • -1.9% IHG.LN (InterContinental Hotels Group £82.04, -1.58) -- Israel launches airstrikes against Iran

        • -1.8% ATORX.SS (Alligator Bioscience SEK3.78, -0.07) -- receives FDA endorsement of mitazalimab Phase 3 dose for pancreatic cancer

    • EU companies reporting tomorrow:

      • Earnings:

        • UK: Peel Hunt (PEEL.LN)

  • Data:

    • Economics:

      • Eurozone Apr

        • Trade Balance €9.9B vs consensus €18.2B and prior €36.8B

        • Industrial Production +0.8% y/y vs cons +1.4% and prior revised +3.7% from +3.6%; (2.4%) m/m vs cons (1.6%) and prior revised +2.4% from +2.6%

      • Germany May CPI +2.1% y/y vs prelim +2.1%; +0.1% m/m vs prelim +0.1%

        • EU Harmonised: +2.1% y/y vs prelim +2.1%; +0.2% m/m vs prelim +0.2%

      • Italy April Trade Balance +€2.5B vs consensus €2.7B and prior revised to €3.657B from €3.657B

      • Spain May CPI +2.0% y/y vs prelim +1.9%; +0.1% m/m vs prelim 0.0%

        • EU Harmonised: +2.0% y/y vs prelim +1.9%; 0.0% m/m vs prelim (0.1%)

      • France May CPI +0.7% y/y vs prelim +0.7%; (0.1%) m/m vs prelim (0.1%)

        • EU Harmonised: +0.6% y/y vs prelim +0.6%; (0.2%) m/m vs prelim (0.2%)

    • Markets:

      • WTI Crude (25-Jul): +$4.26 or +6.26% to $72.30

      • €-$ (0.0017) or (0.14%) to 1.1569

      • £-$ (0.0015) or (0.11%) to 1.3598

      • €-£ (0.0004) to 0.8508

      • S&P 500 (0.52%)

      • Performance year-to-date:

        • FTSE 100: +8.29%

        • DAX: +18.12%

        • CAC: +4.12%

        • MIB: +15.36%

        • Stoxx 600: +7.35%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE